Southwest Wake News

April 23, 2014

Future of Novartis in Holly Springs in question

Novartis and GlaxoSmithKline, two drug makers with major operations in the Triangle, announced Tuesday a three-part deal that involves swapping business units and the creation of a new joint venture focused on over-the-counter medicines. Novartis is also selling its flu business, including its vaccine plant in Holly Springs.

Related content


Editor's Choice Videos